ウイルス学と細菌学の世界市場

ウイルス学と細菌学の世界市場は2030年までに27億米ドルに達する

2024年に22億米ドルと推定されるウイルス学と細菌学の世界市場は、2024年から2030年にかけてCAGR 3.9%で成長し、2030年には27億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである分子診断技術は、CAGR 3.8%を記録し、分析期間終了時には13億米ドルに達すると予測されます。免疫測定技術分野の成長率は、分析期間中CAGR 3.1%と推定されます。

米国市場は5億8,890万米ドルと推定、中国はCAGR7.2％で成長予測

米国のウイルス学と細菌学市場は、2024年に5億8,890万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.2%として、2030年までに5億5,090万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と3.0%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界のウイルス学と細菌学市場- 主要動向と促進要因のまとめ

ウイルス学と細菌学は現代の感染症科学の基盤をどのように形成しているか？

ウイルス学と細菌学は、それぞれウイルスと細菌の研究に焦点を当てた科学分野で、感染症研究と対応の基盤を形成しています。両分野はともに、世界の健康脅威の大部分を引き起こしている微生物の構造、機能、遺伝学、行動に関する重要な洞察を提供しています。過去数十年の間に、分子生物学とゲノム配列決定の進歩は、これらの病原体を検出し、特徴づけ、理解する能力を劇的に向上させました。このような深い理解は、ワクチンや抗菌薬療法の開発のみならず、アウトブレイクの封じ込めと予防を目的とした公衆衛生戦略の策定にも不可欠であることが証明されています。COVID-19のパンデミックはウイルス学的研究の重要性を浮き彫りにし、一方、現在進行中の抗菌薬耐性（AMR）の世界的課題は細菌学的サーベイランスと抗菌薬開発に再び焦点を当てた。両分野とも早期警戒システムに大きく貢献しており、人獣共通感染症の波及や新興感染症が大流行する前に特定することを可能にしています。さらに、現在進行中のバクテリオファージ研究とウイルスベクター応用の研究は、この2つの分野の従来の境界を曖昧にし、治療革新における相互関連性を強調しています。ラボベースの診断から疫学的モデリング、ワクチン設計に至るまで、ウイルス学と細菌学は、相互の結びつきが強まる世界において、新旧の微生物の脅威に立ち向かうために不可欠なものです。病原体が進化するにつれて、それを研究する科学的ツールや共同ネットワークも進化しなければならず、これらの分野への継続的な投資は、世界・ヘルス・セキュリティの要となっています。

どのような技術革新がウイルス学と細菌学調査の進歩を牽引しているのか？

ウイルス学と細菌学の各分野は、より速く、より正確で、より包括的な調査を可能にする技術革新の波によって大きく変貌してきました。最も革新的な開発の一つが次世代シーケンサー（NGS）であり、これにより科学者はウイルスやバクテリアの全ゲノムを数時間で解読できるようになりました。この技術は、新規病原体の迅速な同定、耐性遺伝子の進化の追跡、感染症発生のリアルタイム監視を容易にします。並行して、CRISPRベースの遺伝子編集ツールは、微生物ゲノムを解剖し、宿主と病原体の相互作用を前例のないレベルで詳細に理解するために使用されています。プロテオミクス、トランスクリプトミクス、メタボロミクスは、病原体がどのように機能し、宿主と相互作用するかを理解するためのツールキットをさらに拡張しています。診断の面では、携帯型PCR装置、バイオセンサー、ポイント・オブ・ケア検査が、臨床や現場での感染性病原体の同定に要する時間を大幅に短縮しています。人工知能や機械学習アルゴリズムも、発生動向の予測、薬物-標的相互作用のモデル化、ワクチンや治療薬の設計支援に利用されています。実験室環境では、ハイスループットスクリーニング技術により、細菌やウイルスに対する数千の化合物を同時に調査できるようになり、新しい抗菌薬や抗ウイルス薬の発見が加速しています。このような技術の進歩は、研究をより効率的にするだけでなく、世界中の研究室がツールをより利用しやすくすることで、研究を民主化しています。技術革新が進むにつれ、ウイルス学と細菌学はデジタルヘルスやシステム生物学とさらに統合され、感染症管理へのより積極的で個別化されたアプローチを可能にすると期待されています。

なぜウイルス学と細菌学が世界ヘルスの課題解決の中心なのか？

世界ヘルスの脅威が高まる中、ウイルス学と細菌学の役割は、公衆衛生の準備と対応を確保する上でますます中心的なものとなっています。感染症は、特に低・中所得国において、依然として世界の罹患率と死亡率の主要原因の一つです。HIV、肝炎、インフルエンザ、そして最近ではCOVID-19のようなウイルス性疾患は、医療システムや経済に大きな負担をかけ続けています。一方、結核、肺炎、敗血症などの細菌感染症は、特に抗菌薬耐性によって第一選択薬の抗生物質の多くが効かなくなる中、依然として根強い死因となっています。これらの病原体の生物学、伝播、進化を理解することは、効果的な介入策を開発する上で極めて重要です。ウイルス学は抗ウイルス療法やワクチン設計の枠組みを提供し、細菌学は抗生物質、プロバイオティクス、感染制御プロトコルの開発をサポートします。さらに、ウイルス性細菌性肺炎やHIV関連結核などの共同感染症に取り組む上でも、この2つの分野の相乗効果は不可欠です。また、ウイルス学と細菌学は獣医学や農業衛生にも大きく貢献し、人獣共通感染症や食品安全対策に影響を与えています。人道的・緊急的な状況において、これらの科学はアウトブレイクの発見と制御を支援し、脆弱な集団における疾病の影響を最小限に抑えます。新興感染症の発生が増加し、貿易や旅行が世界化する中、ウイルス学者や細菌学者の役割は、研究室の枠をはるかに超えて広がっています。彼らの仕事は、疾病の撲滅、パンデミックへの備え、進化する微生物の脅威に対応できる強靭なヘルスケアシステムの開発といった世界のイニシアチブを支えています。

ウイルス学と細菌学分野の成長を促進する市場原理と政策イニシアチブは？

ウイルス学と細菌学市場の成長は、感染症管理の緊急性の高まり、ヘルスケアインフラへの投資の増加、世界ヘルスセキュリティへの政策レベルのコミットメントを反映する複数の要因によって牽引されています。主な促進要因としては、感染症発生の増加と、COVID-19以降のパンデミックリスクに対する意識の高まりが挙げられます。政府、保健機関、資金提供機関は、研究、サーベイランス、診断開発により多くの資源を割り当てており、微生物科学を専門とする企業や学術機関に新たな機会をもたらしています。もう一つの重要な要因は抗菌薬耐性の激化で、世界保健機関（WHO）、疾病対策予防センター（CDC）、欧州連合（EU）が新たな抗生物質パイプラインとスチュワードシップ・プログラムを支援するイニシアティブに拍車をかけています。さらに、バイオテクノロジーや製薬セクターの拡大により、ワクチン、治療薬、診断薬の開発のためのウイルス学と細菌学の専門知識を結集した協力体制が促進されています。世界の旅行や貿易の増加により、地域の疾病サーベイランスハブや熟練したウイルス学と細菌学人材に大きく依存する研究所ネットワークの設立も促されています。規制当局は、緊急の公衆衛生上のニーズに応えて新技術の承認プロセスを合理化し、この分野のイノベーションをさらに加速させています。教育機関もまた、現代の課題に取り組むことのできる新世代の微生物学者を育成するために、プログラムを拡充しています。このような動きは、データの共有、研究の優先順位、資金調達メカニズムの調和を目指す官民パートナーシップや国際協力によって強化されています。感染症が世界ヘルスの課題を支配し続ける中、ウイルス学と細菌学は、政策と実践の両輪の中心に不可欠な学問分野としてあり続けると思われます。

セグメント

技術（分子診断技術、免疫測定技術、画像診断技術、情報技術）、エンドユース（病院エンドユース、診断センターエンドユース、研究所エンドユース、血液銀行エンドユース）

調査対象企業の例

• Abbott Laboratories
• Agilent Technologies Inc.
• Becton, Dickinson and Company
• bioMerieux S.A.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Cepheid（Danaher）
• Charles River Laboratories
• F. Hoffmann-La Roche Ltd
• Hologic, Inc.
• Illumina, Inc.
• Lonza Group AG
• Merck KGaA
• PerkinElmer, Inc.
• QIAGEN N.V.
• QuidelOrtho Corporation
• Shimadzu Corporation
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• ZEISS Group

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Virology and Bacteriology Market to Reach US$2.7 Billion by 2030

The global market for Virology and Bacteriology estimated at US$2.2 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Molecular Diagnostics Technology, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Immunoassays Technology segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$588.9 Million While China is Forecast to Grow at 7.2% CAGR

The Virology and Bacteriology market in the U.S. is estimated at US$588.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$550.9 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Virology and Bacteriology Market - Key Trends & Drivers Summarized

How Are Virology and Bacteriology Shaping the Foundation of Modern Infectious Disease Science?

Virology and bacteriology, the scientific disciplines focused on the study of viruses and bacteria respectively, form the bedrock of infectious disease research and response. Together, they provide critical insights into the structure, function, genetics, and behavior of the microorganisms responsible for the vast majority of global health threats. Over the past few decades, advances in molecular biology and genomic sequencing have dramatically enhanced the ability to detect, characterize, and understand these pathogens. This deeper understanding has proven vital not only for the development of vaccines and antimicrobial therapies but also for the formulation of public health strategies aimed at outbreak containment and prevention. The COVID-19 pandemic underscored the importance of virological research, while the ongoing global challenge of antimicrobial resistance (AMR) has refocused attention on bacteriological surveillance and antibiotic development. Both fields contribute substantially to early warning systems, enabling the identification of zoonotic spillovers and emerging infections before they reach pandemic proportions. Additionally, ongoing work in bacteriophage research and viral vector applications is blurring the traditional boundaries between the two disciplines, highlighting their interconnectedness in therapeutic innovation. From lab-based diagnostics to epidemiological modeling and vaccine design, virology and bacteriology remain essential to confronting old and new microbial threats in an increasingly interconnected world. As pathogens evolve, so too must the scientific tools and collaborative networks that study them, making continued investment in these fields a cornerstone of global health security.

What Technological Innovations Are Driving Advances in Virology and Bacteriology Research?

The fields of virology and bacteriology have been revolutionized by a wave of technological innovations that are enabling faster, more accurate, and more comprehensive research. One of the most transformative developments is next-generation sequencing (NGS), which allows scientists to decode the entire genomes of viruses and bacteria in a matter of hours. This technology facilitates rapid identification of novel pathogens, tracks the evolution of resistance genes, and supports real-time surveillance of infectious disease outbreaks. In parallel, CRISPR-based gene editing tools are being used to dissect microbial genomes and understand host-pathogen interactions at an unprecedented level of detail. Proteomics, transcriptomics, and metabolomics are further expanding the toolkit for understanding how pathogens function and interact with their hosts. On the diagnostic front, portable PCR machines, biosensors, and point-of-care tests are drastically reducing the time required to identify infectious agents in clinical and field settings. Artificial intelligence and machine learning algorithms are also being used to predict outbreak trends, model drug-target interactions, and assist in the design of vaccines and therapeutics. In laboratory environments, high-throughput screening technologies are allowing researchers to test thousands of compounds against bacteria and viruses simultaneously, accelerating the discovery of new antimicrobials and antivirals. These technological advances are not only making research more efficient but are also democratizing it by making tools more accessible to laboratories around the world. As innovation continues, virology and bacteriology are expected to become even more integrated with digital health and systems biology, enabling a more proactive and personalized approach to infectious disease management.

Why Are Virology and Bacteriology Central to Addressing Global Health Challenges?

In the face of rising global health threats, the roles of virology and bacteriology have become increasingly central to ensuring public health preparedness and response. Infectious diseases remain one of the leading causes of morbidity and mortality worldwide, particularly in low and middle-income countries. Viral diseases such as HIV, hepatitis, influenza, and more recently, COVID-19, continue to place a heavy burden on healthcare systems and economies. On the other hand, bacterial infections such as tuberculosis, pneumonia, and sepsis remain persistent killers, especially as antimicrobial resistance renders many first-line antibiotics ineffective. Understanding the biology, transmission, and evolution of these pathogens is crucial to developing effective interventions. Virology provides the framework for creating antiviral therapies and designing vaccines, while bacteriology supports the development of antibiotics, probiotics, and infection control protocols. Additionally, the synergy between the two fields is vital in tackling co-infections, such as viral-bacterial pneumonia or HIV-associated tuberculosis. Virology and bacteriology also contribute significantly to veterinary and agricultural health, influencing zoonotic transmission and food safety practices. In humanitarian and emergency contexts, these sciences support outbreak detection and control, minimizing the impact of disease in vulnerable populations. With the increasing incidence of emerging infectious diseases and the globalization of trade and travel, the role of virologists and bacteriologists extends far beyond the laboratory. Their work underpins global initiatives for disease eradication, pandemic preparedness, and the development of resilient healthcare systems capable of responding to evolving microbial threats.

What Market Forces and Policy Initiatives Are Driving Growth in Virology and Bacteriology Sectors?

The growth in the virology and bacteriology market is driven by multiple factors that reflect the growing urgency of infectious disease management, rising investments in healthcare infrastructure, and policy-level commitments to global health security. A major driver is the increasing incidence of infectious disease outbreaks and the heightened awareness of pandemic risks following COVID-19. Governments, health organizations, and funding bodies are allocating more resources to research, surveillance, and diagnostic development, creating new opportunities for companies and academic institutions specializing in microbial science. Another important factor is the intensification of antimicrobial resistance, which has spurred initiatives by the World Health Organization, the Centers for Disease Control and Prevention, and the European Union to support new antibiotic pipelines and stewardship programs. Additionally, the expansion of biotechnology and pharmaceutical sectors is fostering collaborations that bring together expertise in virology and bacteriology for the development of vaccines, therapeutics, and diagnostics. The rise in global travel and trade is also prompting the establishment of regional disease surveillance hubs and laboratory networks that depend heavily on skilled virology and bacteriology personnel. Regulatory agencies are streamlining approval processes for new technologies in response to urgent public health needs, further accelerating innovation in the sector. Educational institutions are also expanding their programs to produce a new generation of microbiologists equipped to tackle modern challenges. These dynamics are being reinforced by public-private partnerships and international collaborations that aim to harmonize data sharing, research priorities, and funding mechanisms. As infectious disease continues to dominate global health agendas, virology and bacteriology will remain indispensable disciplines at the center of both policy and practice.

SCOPE OF STUDY:

The report analyzes the Virology and Bacteriology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology, Information Technology); End-Use (Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use, Blood Banks End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott Laboratories
• Agilent Technologies Inc.
• Becton, Dickinson and Company
• bioMerieux S.A.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Cepheid (Danaher)
• Charles River Laboratories
• F. Hoffmann-La Roche Ltd
• Hologic, Inc.
• Illumina, Inc.
• Lonza Group AG
• Merck KGaA
• PerkinElmer, Inc.
• QIAGEN N.V.
• QuidelOrtho Corporation
• Shimadzu Corporation
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• ZEISS Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Virology and Bacteriology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Global Emergence of Zoonotic Diseases Throws the Spotlight on Integrated Virology-Bacteriology Surveillance
  • Rise in Antimicrobial Resistance Strengthens the Strategic Urgency for Next-Gen Bacteriological Solutions
  • Here's How Genomic Surveillance Technologies Are Redefining Pathogen Detection and Tracking
  • Advances in Synthetic Biology Propel Innovation in Viral and Bacterial Vector Engineering
  • Widening Pipeline of Vaccine Candidates Expands the Role of Virology and Bacteriology in Preventive Medicine
  • Decentralized Diagnostics Push Demand for Rapid, Field-Deployable Virology and Bacteriology Test Platforms
  • Here's the Story: How Climate Change Is Shifting the Geographic Spread of Viral and Bacterial Pathogens
  • Adoption of AI and Bioinformatics Accelerates Pathogen Identification and Outbreak Modeling
  • Surge in Government Preparedness Funding Enhances Global Research Capacity in Pathogen Biology
  • Precision Therapeutics Fuel Targeted Interventions in Drug-Resistant Bacterial Infections and Emerging Viruses
  • Biopharmaceutical Pipeline Diversification Spurs Demand for Dual-Discipline Expertise and Platforms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Virology and Bacteriology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Virology and Bacteriology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Virology and Bacteriology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Virology and Bacteriology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Imaging Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Diagnostic Imaging Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Diagnostic Imaging Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Information Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Information Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Information Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Blood Banks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Blood Banks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Blood Banks End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 47: China Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: China 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 50: China Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: China 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Virology and Bacteriology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Virology and Bacteriology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Virology and Bacteriology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 62: France Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: France 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 65: France Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: France 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 80: UK Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 83: UK Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 86: Spain Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Spain Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Spain 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 89: Spain Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Spain Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Spain 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 92: Russia Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Russia Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Russia 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 95: Russia Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Russia Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Russia 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Rest of Europe Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Rest of Europe 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Rest of Europe Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Rest of Europe 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Virology and Bacteriology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Virology and Bacteriology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Virology and Bacteriology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Asia-Pacific 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Asia-Pacific Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Asia-Pacific 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 113: Australia Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Australia Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Australia 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 116: Australia Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Australia Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Australia 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 119: India Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: India Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: India 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 122: India Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: India Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: India 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 125: South Korea Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: South Korea Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: South Korea 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 128: South Korea Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: South Korea Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: South Korea 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Asia-Pacific Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Asia-Pacific Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Virology and Bacteriology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for Virology and Bacteriology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Latin America 16-Year Perspective for Virology and Bacteriology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 140: Latin America Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Latin America Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Latin America 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 143: Latin America Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Latin America Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Latin America 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 146: Argentina Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Argentina Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Argentina 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 149: Argentina Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Argentina Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Argentina 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 152: Brazil Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Brazil Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Brazil 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 155: Brazil Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Brazil Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Brazil 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 158: Mexico Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Mexico Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Mexico 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 161: Mexico Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Mexico Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Mexico 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Rest of Latin America Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Rest of Latin America 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Rest of Latin America Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Rest of Latin America 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Virology and Bacteriology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for Virology and Bacteriology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Middle East 16-Year Perspective for Virology and Bacteriology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 173: Middle East Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Middle East Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Middle East 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 176: Middle East Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Middle East Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Middle East 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 179: Iran Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Iran Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Iran 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 182: Iran Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Iran Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Iran 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 185: Israel Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Israel Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Israel 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 188: Israel Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Israel Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Israel 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Saudi Arabia Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Saudi Arabia 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Saudi Arabia Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Saudi Arabia 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 197: UAE Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UAE Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: UAE 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 200: UAE Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: UAE Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: UAE 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Middle East Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Middle East 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Middle East Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Rest of Middle East 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Virology and Bacteriology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 209: Africa Recent Past, Current & Future Analysis for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Africa Historic Review for Virology and Bacteriology by Technology - Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Africa 16-Year Perspective for Virology and Bacteriology by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology and Information Technology for the Years 2014, 2025 & 2030
  • TABLE 212: Africa Recent Past, Current & Future Analysis for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Africa Historic Review for Virology and Bacteriology by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Africa 16-Year Perspective for Virology and Bacteriology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use and Blood Banks End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION